Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.…
3 Canadian Penny Stocks To Own In November 2026
Cronos Group (NASDAQ: CRON) is listed on Nasdaq, where its shares trade in USD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 610 employees.
The shares were at 3.040 USD on 20 November 2026, up 19.7% over 52 weeks. Its 52-week range is 2.280 USD to 3.910 USD: the price is 22.3% below the high and 33.3% above the low.
At a market capitalisation of 1.11B USD, it trades at 19.0 times trailing earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.5, a discount of 22% for CRON.
Cronos Group reports return on equity of -0.9%, an operating margin of 6.1% and revenue up 74.6% year over year.
It holds more cash than debt, a net cash position of 739.96M USD. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. One analyst covers the stock, with an average rating of Strong Buy; their mean price target of 2.927 USD is 3.7% below the current price. The next earnings report is expected on 25 February 2027.